High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial
Authors
Keywords
Cancer chemotherapy, Vitamin C, Cancer treatment, Clinical trials (cancer treatment), Chemotherapy, Clinical trials, Computed axial tomography, Oxalic acid
Journal
PLoS One
Volume 10, Issue 4, Pages e0120228
Publisher
Public Library of Science (PLoS)
Online
2015-04-08
DOI
10.1371/journal.pone.0120228
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interference of Intravenous Vitamin C With Blood Glucose Testing
- (2014) Sumangala Vasudevan et al. DIABETES CARE
- Intravenous Vitamin C and Cancer
- (2014) Heidi Fritz et al. INTEGRATIVE CANCER THERAPIES
- Comparative Effectiveness Questions in Oncology
- (2014) Sham Mailankody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin Strikeout
- (2014) Jeffrey M. Drazen et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
- (2014) Y. Ma et al. Science Translational Medicine
- Effects of vitamin C and vitamin D administration on mood and distress in acutely hospitalized patients
- (2013) Yifan Wang et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Parenteral Ascorbate As a Cancer Therapeutic: A Reassessment Based on Pharmacokinetics
- (2013) Nermi L. Parrow et al. ANTIOXIDANTS & REDOX SIGNALING
- Ascorbic acid and its pro-oxidant activity as a therapy for tumours of oral cavity – A systematic review
- (2013) Manisha Chandini Putchala et al. ARCHIVES OF ORAL BIOLOGY
- Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
- (2013) J. L. Welsh et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
- (2013) Christopher M. Stephenson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Manganoporphyrins Increase Ascorbate-Induced Cytotoxicity by Enhancing H2O2 Generation
- (2013) M. Rawal et al. CANCER RESEARCH
- A Convenient Method for Measuring Blood Ascorbate Concentrations in Patients Receiving High-Dose Intravenous Ascorbate
- (2013) Yan Ma et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- High Concentrations of L-Ascorbic Acid Specifically Inhibit the Growth of Human Leukemic Cells via Downregulation of HIF-1α Transcription
- (2013) Hiroshi Kawada et al. PLoS One
- Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress
- (2012) Christoph Klingelhoeffer et al. BMC Complementary and Alternative Medicine
- Intravenous Vitamin C administration reduces fatigue in office workers: a double-blind randomized controlled trial
- (2012) Sang-Yeon Suh et al. Nutrition Journal
- Ascorbic acid alleviates toxicity of paclitaxel without interfering with the anticancer efficacy in mice
- (2012) Jin-Hee Park et al. NUTRITION RESEARCH
- Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
- (2012) Daniel A. Monti et al. PLoS One
- Designing phase II trials in cancer: a systematic review and guidance
- (2011) S R Brown et al. BRITISH JOURNAL OF CANCER
- Systematic Review: Generating Evidence-Based Guidelines on the Concurrent Use of Dietary Antioxidants and Chemotherapy or Radiotherapy
- (2011) Akiko Nakayama et al. CANCER INVESTIGATION
- Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer
- (2011) Michael Graham Espey et al. FREE RADICAL BIOLOGY AND MEDICINE
- High dose of ascorbic acid induces cell death in mesothelioma cells
- (2010) Yukitoshi Takemura et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs
- (2010) Anja Frömberg et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer
- (2010) J. Du et al. CLINICAL CANCER RESEARCH
- Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects
- (2010) Sebastian J. Padayatty et al. PLoS One
- Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects
- (2009) Julien Verrax et al. FREE RADICAL BIOLOGY AND MEDICINE
- Losing and finding a way at C: New promise for pharmacologic ascorbate in cancer treatment
- (2009) Mark Levine et al. FREE RADICAL BIOLOGY AND MEDICINE
- High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis
- (2009) Chang-Hwan Yeom et al. Journal of Translational Medicine
- Oxalic acid excretion after intravenous ascorbic acid administration
- (2009) Line Robitaille et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
- (2008) L. J. Hoffer et al. ANNALS OF ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials
- (2008) Keith I. Block et al. INTERNATIONAL JOURNAL OF CANCER
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
- (2008) Q. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More